These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91. Immunoglobulin-E and anti-IgE treatment in lung disease. Chitkara RK; Sarinas PS; Fick RB Monaldi Arch Chest Dis; 2001 Dec; 56(6):514-20. PubMed ID: 11980283 [TBL] [Abstract][Full Text] [Related]
92. Allergic bronchopulmonary aspergillosis. Model of bronchopulmonary disease with defined serologic, radiologic, pathologic and clinical findings from asthma to fatal destructive lung disease. Greenberger PA; Patterson R Chest; 1987 Jun; 91(6 Suppl):165S-171S. PubMed ID: 3556066 [TBL] [Abstract][Full Text] [Related]
93. Beneficial effects of Omalizumab therapy in allergic bronchopulmonary aspergillosis: A synthesis review of published literature. Li JX; Fan LC; Li MH; Cao WJ; Xu JF Respir Med; 2017 Jan; 122():33-42. PubMed ID: 27993289 [TBL] [Abstract][Full Text] [Related]
94. Allergic bronchopulmonary aspergillosis in two patients with cystic fibrosis. Anadol D; Ozçelik U; Kiper N; Göçmen A Turk J Pediatr; 2000; 42(1):68-71. PubMed ID: 10731875 [TBL] [Abstract][Full Text] [Related]